R-3750

DRUG4 trials

Sponsors

Rise Therapeutics LLC

Conditions

Acute Respiratory Distress SyndromeCOPD (Chronic Obstructive Pulmonary Disease)COPD ExacerbationCOPD Exacerbation AcuteCrohn Disease (CD)Ulcerative ColitisUlcerative Colitis ChronicUlcerative Colitis Chronic Mild

Phase 1

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

RecruitingNCT05666960

Rise Therapeutics LLCUlcerative Colitis, Ulcerative Colitis Chronic, Ulcerative Colitis Chronic Mild +1

Start: 2023-02-27End: 2026-10-01Target: 36Updated: 2026-06-12

A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD

Not yet recruitingNCT07076290

Rise Therapeutics LLCCOPD (Chronic Obstructive Pulmonary Disease), COPD Exacerbation, COPD Exacerbation Acute

Start: 2026-09-01End: 2028-12-31Target: 27Updated: 2026-01-29

R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)

Not yet recruitingNCT07646028

Rise Therapeutics LLCAcute Respiratory Distress Syndrome

Start: 2026-09-01End: 2028-12-31Target: 20Updated: 2026-06-12

R-3750 in Patients With Crohn's Disease

Not yet recruitingNCT07791888

Rise Therapeutics LLCCrohn Disease (CD)

Start: 2026-11-01End: 2029-03-31Target: 40Updated: 2026-08-28